CAF1-5 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
CAF1-5 antibody; At1g61470 antibody; T1F9.4Probable CCR4-associated factor 1 homolog 5 antibody; EC 3.1.13.4 antibody
Target Names
CAF1-5
Uniprot No.

Target Background

Function
The CAF1-5 antibody targets a ubiquitous transcription factor essential for various cellular processes. This factor is a component of the CCR4-NOT complex, which plays a crucial role in regulating gene expression.
Database Links

KEGG: ath:AT1G61470

STRING: 3702.AT1G61470.1

UniGene: At.51196

Protein Families
CAF1 family
Subcellular Location
Nucleus. Cytoplasm.

Q&A

What is the CAF-1 complex and why is it important in chromatin research?

The Chromatin Assembly Factor-1 (CAF-1) is a heterotrimeric complex that plays a crucial role in nucleosome assembly during DNA replication and repair. It consists of three subunits: p150, p60, and p55. CAF-1 mediates chromatin assembly by depositing newly synthesized and acetylated histones H3 and H4 into nascent chromatin during DNA replication . This process is vital for maintaining genomic integrity and regulating gene expression, as proper nucleosome assembly directly affects DNA accessibility to transcription factors and other regulatory proteins . CAF-1 is also involved in heterochromatin maintenance in proliferating cells and plays a role in the coordinated inheritance of gene expression states . The study of CAF-1 provides critical insights into epigenetic regulation, DNA damage response, and cell cycle progression mechanisms.

Which CAF-1 subunit antibodies are available for research applications?

Several antibodies targeting different CAF-1 subunits are available:

  • CAF-1 p150 antibodies: Available as recombinant monoclonal antibodies with various conjugates including Alexa Fluor® 488 . These target the largest subunit (p150/CHAF1A) which serves as the core component of the CAF-1 complex .

  • CAF-1 p60 antibodies: Available as mouse monoclonal antibodies (such as B-10, clone designation) in multiple formats including unconjugated, agarose-conjugated, HRP-conjugated, and fluorophore-conjugated versions (FITC, PE, various Alexa Fluor® conjugates) .

  • CAF-1 p55 antibodies: Available as polyclonal antibodies with various conjugates including biotin . These recognize the smallest subunit of CAF-1.
    Each antibody offers specific advantages depending on the experimental design and target species (human, mouse, rat) .

What experimental applications are supported by CAF-1 antibodies?

CAF-1 antibodies support a diverse range of experimental applications:

Applicationp150 Antibodyp60 Antibodyp55 Antibody
Western Blotting (WB)
Immunoprecipitation (IP)Limited dataLimited data
Immunofluorescence (IF)
Flow Cytometry✓ (intracellular)Limited dataLimited data
Immunohistochemistry (IHC)Limited dataLimited data✓ (paraffin sections)
ELISALimited dataLimited data
The CAF-1 p60 antibody (B-10) has been validated for western blotting, immunoprecipitation, immunofluorescence, and ELISA applications across mouse, rat, and human samples . The p150 antibody conjugated to Alexa Fluor® 488 has been specifically validated for immunocytochemistry/immunofluorescence and flow cytometry applications with human samples .

How should I optimize immunoprecipitation protocols to study CAF-1-interacting proteins?

For optimal immunoprecipitation of CAF-1 and its interacting proteins:

  • Extract preparation: Prepare nuclear extracts from cells expressing CAF-1 (native or tagged versions). For cross-linking immunoprecipitation, harvest approximately 2×10^7 cells and cross-link with dithiobis(succinimidyl propionate) (2 mM) for 15 minutes on ice, followed by quenching with 50 mM Tris (pH 7.5) .

  • Antibody selection: Use well-validated antibodies such as SS24 anti-p60 antibodies for native CAF-1, or anti-HA antibodies (e.g., 12CA5 or 3F10) for HA-tagged CAF-1 proteins .

  • Immunoprecipitation conditions: Incubate extracts with antibody-conjugated beads for 3 hours at 4°C with rotation, followed by washing in appropriate buffers (e.g., Buffer A 100 for nuclear extracts or RIPA buffer for whole cell extracts) .

  • Interactome analysis: Analyze co-precipitated proteins using mass spectrometry (LC-MS/MS) after either direct digestion of precipitates or fractionation using methods such as strong cation exchange chromatography .

  • Validation of interactions: Validate mass spectrometry hits through in vitro co-immunoprecipitation using radiolabeled in vitro translation products to confirm direct interactions .

How can I distinguish between replication-coupled and repair-associated CAF-1 activity in my experiments?

Distinguishing between these two functions requires careful experimental design:

  • Cell cycle synchronization: Synchronize cells at specific cell cycle phases using methods such as double thymidine block or serum starvation followed by release. CAF-1 activity during S-phase is predominantly replication-coupled .

  • DNA damage induction: Induce DNA damage using UV irradiation, radiomimetic drugs, or site-specific endonucleases in non-S phase cells to specifically observe repair-associated CAF-1 recruitment.

  • Co-localization analysis: Use dual immunofluorescence to analyze co-localization of CAF-1 (using antibodies such as Alexa Fluor® 488 Anti-p150) with:

    • PCNA for replication foci

    • γH2AX, 53BP1, or other DNA damage markers for repair sites

  • PCNA-binding mutants: Utilize CAF-1 mutants defective in PCNA binding to distinguish between replication and repair functions, as PCNA interaction is crucial for both processes but can be differentially regulated.

  • Quantitative analysis: Measure the kinetics of CAF-1 recruitment to chromatin after replication inhibition versus DNA damage induction to identify distinct temporal patterns.

What are common causes of non-specific binding with CAF-1 antibodies and how can they be minimized?

Non-specific binding with CAF-1 antibodies can arise from several sources:

  • Antibody concentration: Excessive antibody concentrations often lead to increased background. Titrate antibodies carefully for each application – starting ranges typically include:

    • WB: 1:1000-1:5000 dilution (for concentrated antibodies like SS48 and SS53)

    • IF: 1:100-1:500 dilution

    • IP: 2-5 μg per sample

  • Blocking optimization: Insufficient blocking is a common cause of non-specific binding. Optimize blocking using:

    • 5% non-fat dry milk or BSA in TBST for Western blots

    • 10% serum (from species different from antibody source) for immunofluorescence

    • 1% BSA for flow cytometry applications

  • Antibody specificity: Confirm antibody specificity through:

    • Testing on CAF-1 knockout/knockdown samples as negative controls

    • Using alternative antibody clones targeting different epitopes

    • Pre-adsorption with immunizing peptides when available

  • Cross-reactivity assessment: CAF-1 p55 shares structural similarities with other WD40 repeat proteins, potentially causing cross-reactivity. Validate signals using orthogonal methods or multiple antibodies targeting different subunits .

How should changes in CAF-1 localization patterns be interpreted following experimental manipulations?

Interpreting CAF-1 localization changes requires understanding its functional contexts:

  • Diffuse nuclear to punctate pattern: Transition from diffuse nuclear staining to distinct nuclear foci typically indicates active recruitment to replication sites during S-phase or to DNA damage sites . This pattern change often correlates with increased chromatin assembly activity.

  • Co-localization with heterochromatin: Enhanced association with heterochromatic regions (often co-staining with HP1 proteins) suggests a role in heterochromatin maintenance or assembly, particularly in late S-phase when heterochromatin replicates .

  • Nucleolar exclusion/enrichment: Changes in nucleolar localization may indicate involvement in ribosomal DNA maintenance or repair processes.

  • Cytoplasmic retention: Unexpected cytoplasmic localization might indicate disruption of nuclear import mechanisms or possible novel cytoplasmic functions.

  • Quantitative assessment: For rigorous interpretation, quantify:

    • Percentage of cells showing specific patterns

    • Signal intensity at specific cellular compartments

    • Co-localization coefficients with markers of interest

    • Temporal dynamics using live-cell imaging when possible

What controls are essential when using CAF-1 antibodies in chromatin immunoprecipitation (ChIP) experiments?

Robust ChIP experiments with CAF-1 antibodies require comprehensive controls:

  • Antibody validation controls:

    • Input sample (typically 1-10% of starting material)

    • No-antibody (beads-only) control to assess non-specific binding

    • Isotype control antibody (matching the CAF-1 antibody class and species)

    • ChIP using cells depleted of CAF-1 (siRNA/shRNA treated)

  • Locus-specific controls:

    • Actively replicating regions (positive control for replication-coupled CAF-1)

    • Transcriptionally inactive regions (potential enrichment for heterochromatin-associated CAF-1)

    • Constitutively active housekeeping genes (typically negative control)

  • Experimental validation:

    • Sequential ChIP (re-ChIP) to confirm co-occupancy with known partners (PCNA, newly synthesized histones)

    • Complementary techniques like DNA combing or FAIRE to correlate with replication timing

  • Data analysis recommendations:

    • Normalize to input and IgG control

    • Present data as fold enrichment over background

    • Perform biological replicates (minimum three) for statistical validity

    • Consider cell cycle phase when interpreting results, as CAF-1 chromatin association is highly cell cycle-dependent

How are recent advances in microscopy enhancing our understanding of CAF-1 dynamics?

Advanced microscopy techniques are revolutionizing CAF-1 research:

  • Super-resolution microscopy: Techniques like STORM, PALM, and STED overcome diffraction limits, revealing previously undetectable CAF-1 substructures at replication foci. These methods require highly specific fluorophore-conjugated antibodies, such as the Alexa Fluor® 488 Anti-p150 CAF1/CAF antibody .

  • Live-cell imaging: CRISPR-mediated endogenous tagging of CAF-1 subunits with fluorescent proteins enables real-time tracking of CAF-1 dynamics without antibody-based detection limitations.

  • Single-molecule tracking: Techniques using photoactivatable fluorophore-conjugated antibodies allow tracking of individual CAF-1 complexes, revealing diffusion rates, residence times, and binding kinetics at specific chromatin regions.

  • FRAP and FLIP analyses: These techniques measure CAF-1 mobility and exchange rates between chromatin-bound and soluble pools, providing insights into functional dynamics during replication and repair.

  • Correlative light-electron microscopy: This approach combines fluorescence imaging of antibody-labeled CAF-1 with ultrastructural analysis, revealing its precise localization relative to chromatin ultrastructure. Future methodological improvements should focus on developing antibodies with even greater specificity and sensitivity, particularly for studying the less-characterized p55 subunit, and expanding the range of available conjugates for multiplexed imaging applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.